March 1, 2010
By:Jill Wechsler
FDA is modernizing systems to better access data on drug effects, utilization, and safety.
 |
February 1, 2010
By:Jill Wechsler
New commissioner seeks to expand FDA's capabilities to bring safe and effective drugs to patients.
|
January 1, 2010
By:Jill Wechsler
Globalization and reform initiatives will take part in shaping biomedical research and clinical studies.
|
December 1, 2009
By:Jill Wechsler
A comprehensive listing of U.S. departments and offices that includes the telephone numbers of directors, commissioners, and advisors.
|
November 1, 2009
By:Jill Wechsler
FDA reviewers strive to assess new postmarketing programs while also evaluating applications.
|
October 1, 2009
By:Jill Wechsler
Stiffer enforcement of research standards aims to restore the public's confidence in agency actions.
|
September 1, 2009
By:Jill Wechsler
International health crises expand testing of new vaccines and drug treatments for third-world diseases.
|
August 1, 2009
By:Jill Wechsler
Pressure to reduce health care spending puts R&D, costs, and coverage on the negotiating table.
|
| 
